Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Schachtner

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2016
Estimated nephron number of the remaining donor kidney: impact on living kidney donor outcomesThomas Schachtner, Petra Reinke
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 16, 2016
Pretransplant prophylactic rituximab to prevent Epstein-Barr virus (EBV) viremia in EBV-seronegative kidney transplant recipients from EBV-seropositive donors: results of a pilot studyThomas Schachtner, Petra Reinke
Transplant International : Official Journal of the European Society for Organ Transplantation|May 12, 2015
Different risk factor profiles distinguish early-onset from late-onset BKV-replicationThomas Schachtner, Nina Babel, Petra Reinke
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 16, 2017
Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factorsThomas Schachtner, Maik Stein, Petra Reinke
Clinical Transplantation|April 20, 2017
Diabetic kidney transplant recipients: Impaired infection control and increased alloreactivityThomas Schachtner, Maik Stein, Petra Reinke
Transplant International : Official Journal of the European Society for Organ Transplantation|September 18, 2016
Kidney transplant recipients after nonrenal solid organ transplantation show low alloreactivity but an increased risk of infectionThomas Schachtner, Maik Stein, Petra Reinke
Transplantation|June 9, 2017
CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive DonorThomas Schachtner, Maik Stein, Petra Reinke
Transplant International : Official Journal of the European Society for Organ Transplantation|June 3, 2015
ABO desensitization affects cellular immunity and infection control after renal transplantationThomas Schachtner, Maik Stein, Petra Reinke
Transplant Immunology|December 2, 2016
Increased alloreactivity and adverse outcomes in obese kidney transplant recipients are limited to those with diabetes mellitusThomas Schachtner, Maik Stein, Petra Reinke
Clinical Kidney Journal|January 4, 2021
Two decades of the Eurotransplant Senior Program: the gender gap in mortality impacts patient survival after kidney transplantationThomas Schachtner, Natalie M Otto, Petra Reinke
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2016
Estimated nephron number of the remaining donor kidney: impact on living kidney donor outcomesThomas Schachtner, Petra Reinke
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 16, 2016
Pretransplant prophylactic rituximab to prevent Epstein-Barr virus (EBV) viremia in EBV-seronegative kidney transplant recipients from EBV-seropositive donors: results of a pilot studyThomas Schachtner, Petra Reinke
Transplant International : Official Journal of the European Society for Organ Transplantation|May 12, 2015
Different risk factor profiles distinguish early-onset from late-onset BKV-replicationThomas Schachtner, Nina Babel, Petra Reinke
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 16, 2017
Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factorsThomas Schachtner, Maik Stein, Petra Reinke
Clinical Transplantation|April 20, 2017
Diabetic kidney transplant recipients: Impaired infection control and increased alloreactivityThomas Schachtner, Maik Stein, Petra Reinke
Transplant International : Official Journal of the European Society for Organ Transplantation|September 18, 2016
Kidney transplant recipients after nonrenal solid organ transplantation show low alloreactivity but an increased risk of infectionThomas Schachtner, Maik Stein, Petra Reinke
Transplantation|June 9, 2017
CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive DonorThomas Schachtner, Maik Stein, Petra Reinke
Transplant International : Official Journal of the European Society for Organ Transplantation|June 3, 2015
ABO desensitization affects cellular immunity and infection control after renal transplantationThomas Schachtner, Maik Stein, Petra Reinke
Transplant Immunology|December 2, 2016
Increased alloreactivity and adverse outcomes in obese kidney transplant recipients are limited to those with diabetes mellitusThomas Schachtner, Maik Stein, Petra Reinke
Clinical Kidney Journal|January 4, 2021
Two decades of the Eurotransplant Senior Program: the gender gap in mortality impacts patient survival after kidney transplantationThomas Schachtner, Natalie M Otto, Petra Reinke
Pageof 8